Canton Strategic Holdings (CNTN) Free Cash Flow (2021 - 2026)
Canton Strategic Holdings (CNTN) posted Free Cash Flow of -$7.6 million for Q1 2026, up 26.88% on a QoQ basis from -$10.4 million in Q4 2025, and down 183.94% year-over-year from $9.1 million in Q1 2025.
Canton Strategic Holdings (CNTN) Free Cash Flow (2021 - 2026) Analysis & Trends
Canton Strategic Holdings' Free Cash Flow history runs 6 years deep, the most recent figure standing at -$7.6 million for Q1 2026.
- Quarterly Free Cash Flow fell 183.94% year-over-year to -$7.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$21.1 million (down 95.79% YoY) and the FY2025 annual result came in at -$16.1 million, down 47.97% from the prior year.
- Free Cash Flow was -$7.6 million for Q1 2026 at Canton Strategic Holdings, up from -$10.4 million in the prior quarter.
- Across five years, Free Cash Flow topped out at -$892676.0 in Q4 2022 and bottomed at -$10.4 million in Q4 2025.
- A 5-year average of -$2.9 million and a median of -$2.2 million in 2024 frame the typical range for Free Cash Flow.
- Annual changes were most pronounced in 2022 — Free Cash Flow tumbled 11530.96% — and 2025, when it soared 47.57%.
- Canton Strategic Holdings' Free Cash Flow stood at -$892676.0 in 2022, then plunged by 58.56% to -$1.4 million in 2023, then slumped by 114.19% to -$3.0 million in 2024, then plunged by 244.42% to -$10.4 million in 2025, then gained by 26.88% to -$7.6 million in 2026.
- Business Quant data shows CNTN's Free Cash Flow at -$7.6 million in Q1 2026, -$10.4 million in Q4 2025, and -$1.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.58 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 158.09 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.29 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 848.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.95 Mn |
| 10 | Canton Strategic Holdings | 427.87 Mn | 427.87 Mn | - | -7.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.64 Mn |
| Mar 31, 2026 | -7.64 Mn |
| Dec 31, 2025 | -10.44 Mn |
| Dec 31, 2025 | -10.44 Mn |
| Sep 30, 2025 | -1.86 Mn |
| Sep 30, 2025 | -1.86 Mn |
| Jun 30, 2025 | -1.14 Mn |
| Jun 30, 2025 | -1.14 Mn |
| Mar 31, 2025 | -2.69 Mn |
| Mar 31, 2025 | -2.69 Mn |
| Dec 31, 2024 | -3.03 Mn |
| Dec 31, 2024 | -3.03 Mn |
| Sep 30, 2024 | -2.86 Mn |
| Sep 30, 2024 | -2.86 Mn |
| Jun 30, 2024 | -2.18 Mn |
| Jun 30, 2024 | -2.18 Mn |
| Mar 31, 2024 | -2.83 Mn |
| Mar 31, 2024 | -2.83 Mn |
| Dec 31, 2023 | -1.42 Mn |
| Dec 31, 2023 | -1.42 Mn |